glp-1/gip receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight dual glp 1 and gip
Description
Folli F, Guardado Mendoza R
Treat initial VWAP tests as decision points
Extended data figures and tables Extended Data Fig
While some patients experience diarrhea, others develop constipation, and many notice changes in bowel frequency or consistency
The Need for Further Research While this study establishes a strong association between GLP-1 drugs and ischemic optic neuropathy, more research is needed to determine causality and potential preventive measures
The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
